Form4insider filings, from the source

SEC Form 4 · accession 0000874015-19-000024

IONIS PHARMACEUTICALS INC · IONS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Brett P Monia
Officer — Chief Operating Officer
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 7:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 15, 2019M10,006$0.00A25,847D
Common StockF2Jan 15, 2019F3,572$58.26D22,275D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4,F5—Jan 15, 2019A45,728A——Common Stock45,72845,728D
Restricted Stock UnitsF4,F5—Jan 15, 2019M10,006D——Common Stock10,00620,280D

Explanation of responses